Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.

Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.

Item
http://www.wikidata.org/entity/Q34003020
Collateral Damage: Detrimental Effect of Antibiotics on the Development of Protective Immune MemoryHuman guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response.Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BCImmunity to murine chlamydial genital infection.Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristicsInduction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Chlamydia trachomatis vaccine research through the years.Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infectionA live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.Natural Course of Chlamydia trachomatis Bacterial Load in the Time Interval between Screening and Treatment in Anogenital Samples.The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfectionChlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.A link between neutrophils and chronic disease manifestations of Chlamydia muridarum urogenital infection of mice.
P2860

Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.

Item
http://www.wikidata.org/entity/Q34003020
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@ast
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@en
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@nl
type
label
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@ast
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@en
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@nl
prefLabel
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@ast
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@en
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Subclinical chlamydial infecti ...... ed chlamydial vaccine strains.
@en
P2093
P2860
P304
P31
P356
10.1128/IAI.68.1.192-196.2000
P407
P433
P478
P577
P698
P921
P932